Home › Funds › NEXTBio Capital Management LP › GLUE

NEXTBio Capital Management LP position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

NEXTBio Capital Management LP reported holding 111,455 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.58% of its reported portfolio and ranking #23 among its reported holdings. NEXTBio Capital Management LP first reported this position in Q3 2026.

Latest position (Q3 2026)111.45K sh
Reported value held$1.33M
Portfolio Weight0.58%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's GLUE position evolved

NEXTBio Capital Management LP first disclosed a stake in GLUE in Q3 2026 at 111,455 shares (US$1.3M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 111.45K $1.33M New

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has NEXTBio Capital Management LP held GLUE?

NEXTBio Capital Management LP has disclosed GLUE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is NEXTBio Capital Management LP's current position in GLUE?

As of Q3 2026, NEXTBio Capital Management LP holds 111.45K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $1.33M, representing 0.58% of its reported portfolio and ranking #23.

Has NEXTBio Capital Management LP been buying or selling GLUE?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP newly opened its position in GLUE.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.